Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 12, 2011, Pages 2685-2688

  Wyllie, David ^a   Paul, John ^b   Crook, Derrick ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Epidemic; ST22; ST36

Indexed keywords

CHLORHEXIDINE;

ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; COST OF ILLNESS; EPIDEMIC; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; UNITED KINGDOM;

BACTEREMIA; CROSS INFECTION; GREAT BRITAIN; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCAL INFECTIONS;

EID: 81855190686     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr392     Document Type: Article

References (35)

1. Smith JM, Smith NH, O'Rourke M et al. How clonal are bacteria? Proc Natl Acad Sci USA 1993; 90: 4384-8.
2. HPA. Results From the Mandatory Surveillance of MRSA Bacteraemia. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1233906819629 (7 September 2011, date last accessed).
3. Johnson AP, Aucken HM, Cavendish S et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 2001; 48: 143-4.
4. Hunt AC, Edwards B, Girvan EK et al. Methicillin-resistant Staphylococcus aureus in northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns. J Clin Microbiol 2011; 49: 1975-8.
5. Wyllie DH, Walker AS, Miller R et al. Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. BMJ Open 2011; 1: e000160.
6. Ellington MJ, Hope R, Livermore DM et al. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 2010; 65: 446-8.
7. Grundmann H, Aanensen DM, van den Wijngaard CC et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 2010; 7: e1000215.
8. Boakes E, Kearns AM, Ganner M et al. Molecular diversity within clonal complex 22 methicillin-resistant Staphylococcus aureus encoding Panton-Valentine leukocidin in England and Wales. Clin Microbiol Infect 2011; 17: 140-5.
9. Cox RA, Conquest C, Mallaghan C et al. A major outbreak of methicillinresistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995; 29: 87-106.
10. Richardson JF, Reith S. Characterization of a strain of methicillinresistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 1993; 25: 45-52.
11. Freeman J, Bauer MP, Baines SD et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23: 529-49.
12. Beres SB, Sylva GL, Sturdevant DE et al. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci USA 2004; 101: 11833-8.
13. Henriques-Normark B, Blomberg C, Dagerhamn J et al. The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol 2008; 6: 827-37.
14. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369: 2196-210.
15. Robinson DA, Kearns AM, Holmes A et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillinresistant clone. Lancet 2005; 365: 1256-8.
16. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002; 2: 180-9.
17. Amorim ML, Faria NA, Oliveira DC et al. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J Clin Microbiol 2007; 45: 2881-8.
18. Cooper BS, Medley GF, Stone SP et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA 2004; 101: 10223-8.
19. Iwase T, Uehara Y, Shinji H et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 2010; 465: 346-9.
20. van Gils EJ, Hak E, Veenhoven RH et al. Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS One 2011; 6: e20229.
21. Gupta S, Ferguson N, Anderson R. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 1998; 280: 912-5.
22. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011; 66 Suppl 2: ii41-7.
23. Noskin GA, Rubin RJ, Schentag JJ et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis 2007; 45: 1132-40.
24. de Kraker ME, Wolkewitz M, Davey PG et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011; 55: 1598-605.
25. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.
26. Benning A, Dixon-Woods M, Nwulu U et al. Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase. BMJ 2011; 342: d199.
27. Yokoe DS, Mermel LA, Anderson DJ et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 Suppl 1: S12-21.
28. Tacconelli E, De Angelis G, de Waure C et al. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 546-54.
29. Walker S, Peto TE, O'Connor L et al. Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study. PLoS One 2008; 3: e2378.
30. Garcia-Alvarez L, Holden MT, Lindsay H et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 2011; 11: 595-603.
31. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009; 64: 441-6.
32. Batra R, Cooper BS, Whiteley C et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010; 50: 210-7.
33. Jackson RW, Johnson LJ, Clarke SR et al. Bacterial pathogen evolution: breaking news. Trends Genet 2011; 27: 32-40.
34. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-74.
35. Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10: 1432-41.